title: Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement.
abstract: METHODS
  A patient with residual craniopharyngioma experienced a rapid tumor relapse during growth hormone therapy.
  
  
  OBJECTIVE
  We present this case and remind physicians that it is necessary to reevaluate the safety of growth hormone therapy in patients with residual craniopharyngioma.
authors: Department of Pediatrics, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan.
authors: Dau-Ming
authors: DM
authors: Niu
authors: Wan-Yuo
authors: WY
authors: Guo
authors: Hung-Chi
authors: HC
authors: Pan
authors: Tai-Tong
authors: TT
authors: Wong
mesh_terms: D001827:Body Height / Q000187:drug effects; D002648:Child; D003397:Craniopharyngioma / Q000175:diagnosis* / Q000601:surgery; D006130:Growth Disorders / Q000517:prevention & control; D013006:Growth Hormone / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000601:surgery; D018365:Neoplasm, Residual / Q000601:surgery; D010911:Pituitary Neoplasms / Q000175:diagnosis* / Q000601:surgery; D016634:Radiosurgery; D013997:Time Factors
chemical_list: D013006:Growth Hormone